Ortek Therapeutics

Ortek Therapeutics

Early Stage

Setting a new standard for optimal oral health

Setting a new standard for optimal oral health

Overview

Raised to Date: Raised: $115,088

Total Commitments ($USD)

Platform

StartEngine

Start Date

05/11/2022

Close Date

09/06/2022

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$250

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$22,737,774

Rolling Commitments ($USD)

Status
Funded
Reporting Date

09/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$984

# of Investors

78

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

1998

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

High

Location

Roslyn Heights, New York

Business Type

Growth

Ortek Therapeutics, with a valuation of $22.7 million, is raising funds on StartEngine. The company is revolutionizing the professional and consumer oral care markets with its novel products. The FDA-cleared and patented early cavity detection device of Ortek Therapeutics, Ortek-ECD, helps dental professionals in the early detection of cavities without radiation. Also, Ortek’s BasicBites are soft chews that help to maintain enamel health. Mitchell Goldberg founded Ortek Therapeutics in March 1998. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used to reach larger target audiences and expand marketing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$445,252

$2,145,578

COGS

$112,341

$1,174,308

Tax

$0

$0

 

 

Net Income

$-614,548

$-230,189

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$981,561

$1,547,649

Accounts Receivable

$0

$931,347

Total Assets

$1,406,235

$2,014,889

Short-Term Debt

$28,530

$22,638

Long-Term Debt

$0

$0

Total Liabilities

$28,530

$22,638

Financials as of: 05/11/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Ortek Therapeutics on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $22,737,774
Price per Share: $1.00

Follow company

Follow Ortek Therapeutics on StartEngine 2022

Buy Ortek Therapeutics's Deal Report

Warning: according to the close date for this deal, Ortek Therapeutics may no longer be accepting investments.

Ortek Therapeutics Deal Report

Get KingsCrowd’s comprehensive report on Ortek Therapeutics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Ortek Therapeutics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Ortek Therapeutics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge